Beate Klimm

Summary

Affiliation: University of Cologne
Country: Germany

Publications

  1. pmc The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphoma
    Beate Klimm
    Department I Haematology, Immunology, Infectiology, Intensive Care and Oncology, University Hospital of Cologne, Germany
    Dtsch Arztebl Int 109:893-9. 2012
  2. ncbi request reprint [Hodgkin's disease]
    Beate Klimm
    Department I of Internal Medicine, Trial office GHSG, Herderstr 52, University Hospital Cologne, Germany
    Rev Med Suisse 1:2872-7. 2005
  3. ncbi request reprint Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
    B Klimm
    Department I of Internal Medicine, University Hospital Cologne, Germany
    Ann Oncol 18:357-63. 2007
  4. ncbi request reprint Current treatment and immunotherapy of Hodgkin's lymphoma
    Beate Klimm
    Department I of Internal Medicine, University Hospital Cologne, 50924 Cologne, Germany
    Haematologica 90:1680-92. 2005
  5. ncbi request reprint Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group
    Karolin Behringer
    First Department of Internal Medicine, University Hospital Cologne, Joseph Stelzmann Str 9, 50924 Cologne, Germany
    J Clin Oncol 23:7555-64. 2005
  6. doi request reprint Combined modality treatment of Hodgkin's lymphoma
    Beate Klimm
    From the Department I of Internal Medicine and the German Hodgkin s Study Group GHSG, University Hospital Cologne, Germany
    Cancer J 15:143-9. 2009
  7. doi request reprint Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
    Dennis A Eichenauer
    First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
    Blood 118:4363-5. 2011
  8. doi request reprint Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group
    Beate Klimm
    University Hospital of Cologne, Cologne, Germany
    J Clin Oncol 29:3914-20. 2011
  9. doi request reprint First-line treatment of Hodgkin's lymphoma
    Beate Klimm
    First Department of Internal Medicine, University Hospital Cologne, Herderstr 52, 50931 Cologne, Germany
    Curr Hematol Malig Rep 1:51-9. 2006
  10. ncbi request reprint First-line treatment of Hodgkin's lymphoma
    Beate Klimm
    First Department of Internal Medicine, University Hospital Cologne, Herderstr 52, 50931 Cologne, Germany
    Curr Hematol Rep 4:15-22. 2005

Collaborators

Detail Information

Publications16

  1. pmc The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphoma
    Beate Klimm
    Department I Haematology, Immunology, Infectiology, Intensive Care and Oncology, University Hospital of Cologne, Germany
    Dtsch Arztebl Int 109:893-9. 2012
    ..In this study, we aim to measure the effect of the type of treatment center and/or the number of patients treated in it on the outcome of patients with Hodgkin's lymphoma...
  2. ncbi request reprint [Hodgkin's disease]
    Beate Klimm
    Department I of Internal Medicine, Trial office GHSG, Herderstr 52, University Hospital Cologne, Germany
    Rev Med Suisse 1:2872-7. 2005
  3. ncbi request reprint Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
    B Klimm
    Department I of Internal Medicine, University Hospital Cologne, Germany
    Ann Oncol 18:357-63. 2007
    ..Since many of these patients receive combined modality treatment, we evaluated the impact of different radiation field sizes, that is extended-field (EF) or involved-field (IF) technique when given after four cycles of chemotherapy...
  4. ncbi request reprint Current treatment and immunotherapy of Hodgkin's lymphoma
    Beate Klimm
    Department I of Internal Medicine, University Hospital Cologne, 50924 Cologne, Germany
    Haematologica 90:1680-92. 2005
    ..Radioimmunoconjugates and monoclonal antibodies have demonstrated some clinical efficacy. Here, we review new aspects in the treatment of primary and relapsed Hodgkin's lymphoma as well as recent immunotherapeutic approaches...
  5. ncbi request reprint Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group
    Karolin Behringer
    First Department of Internal Medicine, University Hospital Cologne, Joseph Stelzmann Str 9, 50924 Cologne, Germany
    J Clin Oncol 23:7555-64. 2005
    ..Among these, infertility for female patients is of major importance. The subject of this analysis is to evaluate the menstrual status after HL therapy...
  6. doi request reprint Combined modality treatment of Hodgkin's lymphoma
    Beate Klimm
    From the Department I of Internal Medicine and the German Hodgkin s Study Group GHSG, University Hospital Cologne, Germany
    Cancer J 15:143-9. 2009
    ..Here, we review results from current clinical trials and discuss new therapeutic approaches in the combined modality treatment of HL...
  7. doi request reprint Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
    Dennis A Eichenauer
    First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
    Blood 118:4363-5. 2011
    ..This study was registered at www.clinicaltrials.gov as #NCT00346684...
  8. doi request reprint Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group
    Beate Klimm
    University Hospital of Cologne, Cologne, Germany
    J Clin Oncol 29:3914-20. 2011
    ..To investigate the clinical characteristics and treatment outcome of patients with lymphocyte-depleted classical Hodgkin's lymphoma (LDCHL) compared with other histologic subtypes of Hodgkin's lymphoma (HL)...
  9. doi request reprint First-line treatment of Hodgkin's lymphoma
    Beate Klimm
    First Department of Internal Medicine, University Hospital Cologne, Herderstr 52, 50931 Cologne, Germany
    Curr Hematol Malig Rep 1:51-9. 2006
    ..This review discusses recent approaches to the first-line treatment of early-favorable, early-unfavorable, and advanced-stage Hodgkin's lymphoma...
  10. ncbi request reprint First-line treatment of Hodgkin's lymphoma
    Beate Klimm
    First Department of Internal Medicine, University Hospital Cologne, Herderstr 52, 50931 Cologne, Germany
    Curr Hematol Rep 4:15-22. 2005
    ..Here, we review recent approaches in the first-line treatment of early-favorable, early-unfavorable, and advanced-stage HL...
  11. ncbi request reprint Hodgkin's lymphoma in the elderly: a different disease in patients over 60
    Beate Klimm
    German Hodgkin Study Group, Department of Internal Medicine, University Hospital Cologne, Germany
    Oncology (Williston Park) 21:982-90; discussion 990, 996, 998 passim. 2007
    ..Besides the evaluation of specific causes and risk factors, this review highlights recent and ongoing studies for elderly patients with HL as well as international approaches and recommendations for this age group...
  12. ncbi request reprint Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
    Beate Klimm
    First Department of Internal Medicine, University Hospital Cologne, Germany
    J Clin Oncol 23:8003-11. 2005
    ..We systematically investigated sex differences with regard to pretreatment characteristics and therapy-related variables, and examined their influence on the outcome of HL patients...
  13. doi request reprint Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies
    Beate Klimm
    Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    Nat Clin Pract Oncol 5:316-23. 2008
    ..In addition, we highlight the potential causes of hematotoxicity and its impact on treatment outcome and the role of future strategies...
  14. doi request reprint Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group
    Diana Wongso
    Department of Internal Medicine I, Cologne University Hospital, Kerpener Str 62, 50924 Cologne, Germany
    J Clin Oncol 31:2819-24. 2013
    ..9%. CONCLUSION The individual risk of TRM associated with BEACOPPescalated can be predicted by a simple algorithm based on age and PS. High-risk patients should receive special clinical attention. ..
  15. ncbi request reprint Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity
    Stefan Wilde
    Department of Pharmacology, University Hospital, University of Cologne, Cologne, Germany
    Clin Pharmacokinet 46:319-33. 2007
    ..The present study was conducted to address the role of pharmacokinetics in individual toxicity...
  16. ncbi request reprint Axillary swelling and a reduced general condition in a middle-aged man
    Beate Klimm
    Department I of Internal Medicine GHSG, University of Cologne, Cologne, Germany
    Nat Clin Pract Oncol 1:51-4; quiz 1 p following 54. 2004
    ..5-2.0 cm in the left cervical region. Laboratory tests were unremarkable, except for an elevated erythrocyte sedimentation rate...